The vitro efficacy of β-lactam and β-lactamase inhibitors against multidrug resistant clinical strains of Mycobacterium tuberculosis
- 30 April 2004
- journal article
- case report
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 23 (4), 408-411
- https://doi.org/10.1016/j.ijantimicag.2003.09.023
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Synergistic antimycobacterial activity between ethambutol and the beta-lactam drug cefepimeDiagnostic Microbiology and Infectious Disease, 1997
- Evolution and Dissemination of β-Lactamases Accelerated by Generations of β-Lactam AntibioticsClinical Infectious Diseases, 1997
- Drug-Resistant Tuberculosis: Review of the Worldwide Situation and the WHO/IUATLD Global Surveillance ProjectClinical Infectious Diseases, 1997
- Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis?Antimicrobial Agents and Chemotherapy, 1995
- Drug-resistant tuberculosis: laboratory issues: World Health Organization recommendationsTubercle and Lung Disease, 1994
- Beta-Lactamase Inhibitors and the Inducibility of the Beta-Lactamase ofMycobacterium tuberculosisAmerican Review of Respiratory Disease, 1992
- In-vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium kansasii to amoxycillin and ticarcillin in combination with clavulanic acidJournal of Antimicrobial Chemotherapy, 1988
- Comparison of four β-lactamase inhibitors in combination with ampicillin against Mycobacterium tuberculosisJournal of Antimicrobial Chemotherapy, 1987
- In vitro susceptibility ofMycobacterium tuberculosis,Mycobacterium fortuitum andMycobacterium chelonei to augmentinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- In vitro activity of amoxicillin in combination with clavulanic acid against Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 1983